💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Ingevity finalizes termination of key supply agreement

EditorNatashya Angelica
Published 07/08/2024, 04:34 PM
NGVT
-

Ingevity Corp (NYSE:NGVT) has confirmed the termination of a significant crude tall oil supply agreement with GP Pine Chemicals, LLC, a subsidiary of Georgia-Pacific, according to a recent SEC filing. The termination, effective as of July 1, 2024, ends the company's obligations to purchase crude tall oil from Georgia-Pacific, which had been in place since March 8, 2018.

The termination agreement stipulates that Ingevity will pay Georgia-Pacific $50 million as the first installment on the termination date and another $50 million by October 15, 2024. Additionally, Ingevity has committed to an additional purchase of crude tall oil in July 2024 if their June purchases did not meet specified volume thresholds.

This strategic move provides Ingevity with more flexibility as it plans to restructure its Performance Chemicals business segment to better focus on specialty chemicals markets. Details on the restructuring and potential impacts on the company's operations are expected to be disclosed as decisions are finalized.

The termination agreement includes a mutual release and other customary terms such as non-disparagement and confidentiality provisions. The SEC filing indicates that all obligations under the original supply agreement were suspended as of the termination date, except for outstanding payment obligations for products supplied prior to the suspension date and the June purchase obligations.

Ingevity's management is actively evaluating significant restructuring steps for 2024, aiming to position the Performance Chemicals business segment more favorably in the specialty chemicals markets. This development is part of the company's broader strategy to optimize its operations and product offerings.

The information provided in this article is based on the SEC filing by Ingevity Corp.

In other recent news, Ingevity Corporation has reported a robust start to the first quarter of 2024, with key segments exceeding expectations, particularly the Performance Materials segment which delivered strong margins.

The company maintained its full-year guidance, projecting sales between $1.4 billion and $1.55 billion and adjusted EBITDA from $365 million to $390 million. However, Ingevity also faces persistent challenges with its Crude Tall Oil operations, expected to continue into the third quarter.

Ingevity has announced a significant change in its executive team with the resignation of Executive Vice President, General Counsel, and Secretary, Stacy L. Cozad. Ryan C. Fisher has been appointed to succeed Cozad. BMO Capital Markets and Loop Capital have adjusted their price targets for Ingevity, reflecting the company's strong performance and potential in the Performance Materials segment.

These are recent developments in the company's operations. Ingevity is actively exploring alternatives for its AFA/OLEO-based products within its Performance Chemicals division. However, both BMO Capital Markets and Loop Capital express a neutral stance on the risk/reward balance for Ingevity's stock due to ongoing transformations and uncertainties.

InvestingPro Insights

As Ingevity Corp (NYSE:NGVT) navigates the termination of a key supply agreement and restructures its Performance Chemicals segment, investors may keep a close eye on the company's financial health and market position.

Key metrics from InvestingPro show a market capitalization of $1.52 billion and a forward P/E ratio for the next twelve months as of Q1 2024 at 21.11, reflecting investor expectations for future earnings. Despite recent revenue declines—2.29% over the last twelve months as of Q1 2024—the company's gross profit margin stands at a robust 28.17%, indicating a strong ability to control costs relative to sales.

InvestingPro Tips suggest a mixed outlook: analysts are predicting net income growth for the year, yet there have been several downward earnings revisions for the upcoming period. Moreover, the stock's recent volatility and lack of dividends may be of concern to some investors. But with a current RSI suggesting the stock is in oversold territory, there may be potential for a rebound.

For those interested in a deeper analysis, there are additional tips available on InvestingPro, and by using the coupon code PRONEWS24, readers can get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.